|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Loss on issuance of common stock | |||||
| Placement agent warrant offering expense | |||||
| Gain on previously liquidated equity securities | |||||
| Gain on sale of asset | |||||
| Interest accretion on escrow receivable | |||||
| Accretion on investments | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Non-cash lease expense | |||||
| Inventory write-off | |||||
| Increase (decrease) in cash resulting from changes in: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Operating right-of-use asset and lease liability, net | |||||
| Operating lease liability | |||||
| Net cash used in operating activities | |||||
| Cash Flows From Investing Activities | |||||
| Purchases of fixed assets | |||||
| Proceeds from sale of asset | |||||
| Purchases of investments | |||||
| Maturities of investments | |||||
| Proceeds from previously liquidated equity securities | |||||
| Purchases of equity securities | |||||
| Proceeds from sales of equity securities | |||||
| Liquidation of equity securities | |||||
| Net cash provided by investing activities | |||||
| Cash Flows From Financing Activities | |||||
| Proceeds from issuance of common stock, net | |||||
| Repayment of insurance premium financing liability | |||||
| Net cash provided by financing activities | |||||
| Net (Decrease) Increase in Cash, Cash Equivalents, and Restricted Cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Supplemental Disclosure of Cash Flow Information: | |||||
| Escrow receivable | |||||
| Income taxes paid | |||||
| Interest paid | |||||
| Liability to be settled in equity | |||||
| Financed insurance premium exchanged for prepaid insurance | |||||
| Common stock warrant liabilities | |||||
| Purchases of fixed assets in accounts payable | |||||
| Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...